Revenue: USD 71,000 in QQ3 2024, down 18.39% year over year and down 32.38% quarter over quarter (YoY and QoQ declines driven by a minimal commercial base and ongoing pre-revenue status).
Gross Profit: USD 10,000; gross margin 14.08%; YoY margin deterioration of 88.51% with a QoQ rebound of 100.20% (reflecting minimal revenue and fixed cost base).
Operating Income: USD -5,534,000; operating margin -77.94%; YoY improvement of 22.06% in operating income (still deeply negative due to R&D intensity) and QoQ decline of 6.16%.
Net Income: USD -5,293,000; net margin -74.55%; YoY improvement of 30.57% but QoQ decline of 7.91% as operating losses dominate.
EPS (Diluted): -USD 1.01; YoY improvement 33.55%, QoQ decline 5.21%.
EBITDA: USD -5,111,000; EBITDA margin -71.99%.
Cash Flow: Operating cash flow USD -4,202,000; free cash flow USD -4,291,000; net cash provided by investing activities USD -5,668,000 despite USD 5,690,000 maturities of investments and USD 67,000 purchases, with a net positive forex impact of USD 39,000.
Liquidity and Leverage: Cash and cash equivalents USD 7.35m; short-term investments USD 18.93m; total cash and equivalents USD 26.28m. Total assets USD 36.39m; total liabilities USD 34.55m; long-term debt USD 29.41m; total debt USD 30.08m; net debt USD 22.73m. Current ratio 6.05x; cash ratio 1.63x. Shareholders’ equity is negative USD 0.356m, reflecting accumulated deficits against a backdrop of substantial non-current liabilities. Per-share metrics reflect a USD -1.01 reported EPS and negative leverage across most profitability dimensions.